An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors

Supportive Care in Cancer

Volumn 20, Issue 7, 2012, Pages 1361-1375

  Cheung, Yin Ting ^a   Tan, Earl Hsien Jie ^a   Chan, Alexandre ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Cancer; Chemotherapy; Cognitive function; Neuropsychological; Oncology

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; THIOTEPA;

ATTENTION; ATTENTION FUNCTION INDEX; AUDITORY VERBAL LEARNING TEST; AUTOMATION; BENTON VISUAL RETENTION TEST; BOSTON NAMING TEST; BREAST CANCER; BUSCHKE SELECTIVE REMINDING TASK; CALIFORNIA VERBAL LEARNING TEST; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; CANCER CHEMOTHERAPY; COGNITION; COGNITIVE DEFECT; COGNITIVE FAILURE QUESTIONNAIRE; CONNER CONTINUOUS PERFORMANCE TEST II; CONTROLLED ORAL WORD ASSOCIATION TEST; DELIS KAPLAN EXECUTIVE FUNCTION SYSTEM; DUTCH APHASIA SOCIETY TEST; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; EXECUTIVE FUNCTION; FINGER TAPPING; FUNCTIONAL ASSESSMENT OF CANCER THERAPY COGNITIVE VERSION 3; GENERAL HEALTH QUESTIONNAIRE; GROOVED PEGBOARD; HIGH SENSITIVITY COGNITIVE SCREEN; HOPKINS VERBAL LEARNING TEST; HUMAN; INTELLIGENCE; LANGUAGE ABILITY; MEMORY; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; MULTILINGUAL APHASIA EXAMINATION; MULTIPLE ABILITIES SELF REPORT QUESTIONNAIRE; NATIONAL ADULT READING TEST; NEUROPSYCHOLOGICAL TEST; PACED AUDITORY SERIAL ADDITION TEST; PERCEPTION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REPEATED BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; REVIEW; REY OSTERRIETH COMPLEX FIGURE TEST; SYMBOL DIGIT MODALITIES TEST; SYSTEMATIC REVIEW; TEST FOR EVERYDAY ATTENTION; TREATMENT OUTCOME; VERBAL NONVERBAL SELECTIVE REMINDING TEST; WECHSLER ABBREVIATED SCALE OF INTELLIGENCE; WECHSLER ADULT INTELLIGENCE SCALE 3RD EDITION; WECHSLER ADULT INTELLIGENCE SCALE REVISED EDITION; WECHSLER MEMORY SCALE 3RD EDITION; WECHSLER MEMORY SCALE REVISED EDITION; WIDE RANGE ACHIEVEMENT TEST 3; WISCONSIN CARD SORTINGTEST;

EID: 84984548408     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1445-4     Document Type: Review

References (108)

1. Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703-708
2. Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A (2012) Cognitive changes in multiethnic Asian breast cancer patients: A focus group study. Ann Oncol. doi:10.1093/annonc/MDS1029
3. Cheung YT, ChuiWK, Chan A (2011) Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2011.1009.1001 [Article in press]
4. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice Cognitive Workshop. Ann Oncol 19:623-629
5. Vardy J, Tannock IF (2007) Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 63:183-202
6. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2010) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19:1647-1656
7. Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J (2008) Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psycho-Oncology 17:1189-1195
8. Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, van Rhijn D, Rodenhuis S, van Dam FSAM (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387-1397
9. Vardy J, Rourke S, Tannock IF (2007) Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 25:2455-2463
10. Hurria A, Lachs M (2007) Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Res Treat 103:259-268
11. Pullens MJJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 19:1127-1138
12. Phillips K-A, Bernhard J (2003) Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst 95:190-197
13. Shilling V, Jenkins V, Trapala IS (2006) The (mis) classification of chemo-fog-methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 95:125-129
14. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9:967-982
15. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104:2222-2233
16. Strauss E, Sherman EMS, Otfried S (2006) A compendium of neuropsychological tests. Oxford University Press, New York
17. Scherwath A, Mehnert A, Schleimer B, Schirmer L, Fehlauer F, Kreienberg R, Metzner B, Thiel E, Zander AR, Schulz-Kindermann F, Koch UT (2006) Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. Ann Oncol 17:415-423
18. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U (2007) The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 66:108-118
19. Debess J, Riis JO, Engebjerg MC, Ewertz M (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 121:91-100
20. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28:4434-4440
21. Mehlsen M, Pedersen AD, Jensen AB, Zachariae R (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology 18:248-257
22. Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S (2009) Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology 18:134-143
23. Reid-Arndt SA, Yee A, Perry MC, Hsieh C (2009) Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 27:415-434
24. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology 15:422-430
25. Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, Oxford
26. Rabin LA, Barr WB, Burton LA (2005) Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members. Arch Clin Neuropsychol 20:33-65
27. Camara WJ, Nathan JS, Puente AE (2000) Psychological test usage: implications in professional psychology. Prof Psychol Res Pr 31:141-154
28. Smith GE, Malec JF, Ivnik RJ (1992) Validity of the construct of nonverbal memory: a factor-analytic study in a normal elderly sample. J Clin Exp Neuropsychol 14:211-221
29. Lees-Haley PR, Greiffenstein MF, Larrabee GJ, Manning EL (2004) Methodological problems in the neuropsychological assessment of effects of exposure to welding fumes and manganese. Clin Neuropsychol 18:449-464
30. Flanagan DP, McGrew KS, Ortiz SO (2000) The Wechsler Intelligence Scales and Gf-Gc theory: a contemporary approach to interpretation. McGraw-Hill, Boston
31. Hammes JGW (1978) De Stroop Kleur-Woord Test. Handleiding, Tweede Gewijzigde Druk. [The Stroop color-word test. Manual, 2nd edn]. Swets & Zeitlinger, Lisse
32. Rey A (1941) L'Examen Psychologie dans Les Cas D'encephalopathie Traumatique. [The psychological examination in cases of traumatic encephalopathy]. Arch de Psychologie 23:286-228
33. Reitan RM (1958) Validity of the Trail Making Test As An Indicator Of Organic Brain Damage. Percept Mot Skills 8:271-286
34. Kulas JF, Axelrod BN (2002) Comparison of seven-subtest and Satz-Mogel short forms of the WAIS-III. J Clin Psychol 58:773-782
35. Ryan JJ, Lopez SJ, Werth TR (1999) Development and preliminary validation of a Satz-Mogel short form of the WAIS-III in a sample of persons with substance abuse disorders. Int J Neurosci 98:131-140
36. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
37. Randolph C, Tierney MC, Mohr E, Chase TN (1998) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20:310-319
38. Faust D, Fogel BS (1989) The development and initial validation of a sensitive bedside cognitive screening test. J Nerv Ment Dis 177:25-31
39. Vardy J, Wong K, Yi Q-L, Park A, Maruff P, Wagner L, Tannock IF (2006) Assessing cognitive function in cancer patients. Support Care Cancer 14:1111-1118
40. Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175-4183
41. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695-2701
42. Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Segura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F (2010) One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 81:795-803
43. Minisini AM, De Faccio S, Ermacora P, Andreetta C, Fantinel R, Balestrieri M, Piga A, Puglisi F (2008) Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study. Crit Rev Oncol Hematol 67:71-79
44. Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101:404-411
45. Yamada TH, Denburg NL, Beglinger LJ, Schultz SK (2010) Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22:48-54
46. Elwood DL, Griffin HR (1972) Individual intelligence testing without the examiner: reliability of an automated method. J Consult Clin Psychol 38:9-14
47. CogState Limited (2011) CogState Research http://www.cogstate.com/go/ research. Accessed 30 March 2012.
48. Fray PJ, Robbins TW (1996) CANTAB battery: proposed utility in neurotoxicology. Neurotoxicol Teratol 18:499-504
49. Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J (2002) Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 17:458-476
50. Homack S, Riccio CA (2006) Conners' continuous performance test (2nd edn; CCPT-II). J Atten Disord 9:556-558
51. Feldstein SN, Keller FR, Portman RE, Durham RL, Klebe KJ, Davis HP (1999) A comparison of computerized and standard versions of the Wisconsin Card Sorting Test. Clin Neuropsychol 13:303-313
52. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I (2003) Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc 9:64-71
53. Miller EN, Satz P, Visscher B (1991) Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology 41:1608-1616
54. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR (1982) The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21(Pt 1):1-16
55. Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A (1994) Development and validation of a multiple ability selfreport questionnaire. J Clin Exp Neuropsychol 16:93-104
56. Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116:113-123
57. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26:955-969
58. Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 11:6-15
59. Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G, Shah E, Stein R, Whitehead S, Winstanley J (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828-834
60. Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, Van den Stock J, Smeets A, Christiaens MR, Leemans A, Van Hecke W, Vandenberghe J, VandenbulckeM, Sunaert S (2011) Chemotherapyinduced structural changes in cerebralwhite matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32:480-493
61. Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB (2005) Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104:2499-2507
62. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA (2007) Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25:3866-3870
63. Jim HSL, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB (2009) Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 115:1776-1783
64. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F (1993) The European Organisation for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in International clinical trials in oncology. J Natl Cancer Inst 85:365-376
65. Ruzich M, Ryan B, Owen C, Delahunty A, Stuart-Harris R (2007) Prospective evaluation of cognitive function in patients with early breast cancer receiving adjuvant chemotherapy. Asia Pac J Clin Oncol 3:123-133
66. Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FSAM (2001) Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 51:159-165
67. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210-218
68. Skaali T, Foss SD, Dahl AA (2011) A prospective study of cognitive complaints in patients with testicular cancer. Clin Genitourin Cancer 9:6-13
69. Gan HK, Bernstein LJ, Brown J, Ringash J, Vakilha M, Wang L, Goldstein D, Kim J, Hope A, O'Sullivan B, Waldron J, Abdul Razak AR, Chen EX, Siu LL (2011) Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 81:126-134
70. Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IGH, Schlegel U (2010) Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67:182-189
71. Taillibert S, Voillery D, Bernard-Marty C (2007) Chemobrain: is systemic chemotherapy neurotoxic? Curr Opin Oncol 19:623-627
72. Schatz P, Browndyke J (2002) Applications of computer-based neuropsychological assessment. J Head Trauma Rehabil 17:395-410
73. Saykin AJ, Ahles TA, McDonald BC (2003) Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8:201-216
74. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2010) Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 123:819-828
75. Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YKK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123:25-34
76. Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348-3356
77. Biglia N, Moggio G, Peano E, Sgandurra P, Ponzone R, Nappi RE, Sismondi P (2010) Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. J Sex Med 7:1891-1900
78. Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G (2009) Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15:951-962
79. Hermelink K, UntchM, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Munzel K (2007) Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109:1905-1913
80. Downie FP, Mar Fan HG, Houede-Tchen N, Yi Q, Tannock IF (2006) Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho-Oncology 15:921-930
81. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA (2004) 'Chemobrain' in breast carcinoma?: a prologue. Cancer 101:466-475
82. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100:2292-2299
83. Servaes P, Verhagen CA, Bleijenberg G (2002) Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 95:2017-2026
84. Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 4:61-66
85. Kreukels BP, van Dam FS, Ridderinkhof KR, BoogerdW, Schagen SB (2008) Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer 8:80-87
86. Gottschalk LA, Holcombe RF, Jackson D, Bechtel RJ (2003) The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Methods Find Exp Clin Pharmacol 25:117-122
87. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640-650
88. Falleti MG, Maruff P, Collie A, Darby DG (2006) Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol 28:1095-1112
89. French CC, Beaumont JG (1987) The reaction of psychiatric patients to computerized assessment. Br J Clin Psychol 26:267-278
90. Collie A, Maruff P, McStephen M, Darby DG (2003) Psychometric issues associated with computerised neuropsychological assessment of concussed athletes. Br J Sports Med 37:556-559
91. Collie A, Maruff P (2003) Computerised neuropsychological testing. Br J Sports Med 37:2-3
92. Collie A, Maruff P, Makdissi M, McCrory P, McStephen M, Darby D (2003) CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med 13:28-32
93. Conners CK, Staff M (2000) Conners' Continuous Performance Test (CPT II) computer programs for Windows technical guide and software manual. Multi-Health Systems, North Tonawanda
94. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
95. Cimprich B, Visovatti M, Ronis DL (2011) The Attentional Function Index-a self-report cognitive measure. Psycho-Oncology 20:194-202
96. Goldberg D, Williams P (1988) A user's guide to the general health questionnaire. NFER-Nelson, Windsor
97. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570-579
98. Duff K, Beglinger LJ, Schoenberg MR, Patton DE, Mold J, Scott JG, Adams RL (2005) Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample. J Clin Exp Neuropsychol 27:565-575
99. Nelson HE (1982) National Adult Reading Test (NART): test manual. NFER Nelson, Windsor
100. Blair JR, Spreen O (1989) Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsychol 3:129-136
101. Crawford JR, Stewart LE, Besson JAO, Parker DM, De Lacey G (1989) Prediction of WAIS IQ with the National Adult reading test: Cross-validation and extension. Br J Clin Psychol 28:267-273
102. Raguet ML, Campbell DA, Berry DTR, Schmitt FA, Smith GT (1996) Stability of intelligence and intellectual predictors in older persons. Psychol Assess 8: 154-160
103. Mitrushina M, Satz P (1991) Effect of repeated administration of a neuropsychological battery in the elderly. J Clin Psychol 47:790-801
104. Shapiro AM, Benedict RH, Schretlen D, Brandt J (1999) Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol 13:348-358
105. Kaplan EF, Goodglass H, Weintraub S (2001) The Boston naming test, 2nd edn. Lippincott Williams & Wilkins, Philadelphia
106. Flanagan JL, Jackson ST (1997) Test-retest reliability of three aphasia tests: performance of non-brain-damaged older adults. J Commun Disord 30:33-42
107. Mitrushina M, Satz P (1995) Repeated testing of normal elderly with the Boston naming test. Aging 7:123-127
108. Ross TP, Calhoun E, Cox T, Wenner C, Kono W, Pleasant M (2007) The reliability and validity of qualitative scores for the Controlled Oral Word Association Test. Arch Clin Neuropsychol 22:475-488